Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02926768
Title Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Checkpoint Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NZL | AUS


No variant requirements are available.